Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company
August 3, 2026
Biotechnology
-
-
Compugen Reports Second Quarter 2026 Results
August 3, 2026
-
Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome
August 3, 2026
-
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
August 3, 2026
-
Cerenome Launches as an Integrated CNS Oncology Company
July 31, 2026
-
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
July 31, 2026
-
SciSparc: Subsidiary NeuroThera Labs’ Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics
July 31, 2026
-
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab
July 31, 2026
-
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
July 31, 2026
-
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
July 31, 2026
-
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
July 31, 2026
-
Leading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients
July 30, 2026
-
Curis Doses First Five Patients in TakeAim CLL Study
July 30, 2026
-
MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF
July 29, 2026
-
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
July 27, 2026
-
NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to License
July 27, 2026